Exons 4 to 9 of the mouse Capns1 (calpain, small subunit 1) gene are flanked by loxP sites in this conditional mutant strain that is useful for studying protein function in neuronal injury.
Stan Krajewski, Sanford/Burnham Medical Research Institute
Calp mutant mice possess loxP sites flanking exons 4-9 of the Capns1 or calpain, small subunit 1 gene. Calpains are calcium-dependent cysteine proteinases involved in multiple cellular functions; in particular they have been implicated in neurodegenerative diseases. Heterozygous mice are viable and fertile, however, homozygous embryos exhibit lethality prior to E10.5. When bred to mice that express tissue-specific Cre recombinase, resulting offspring will have exons 4-9 deleted in the cre-expressing tissues. This allele causes in embryonic lethality in the homozygous state.
For example, when bred to mice carrying a pan-neuronal CRE3 transgene, mice exhibit impaired performance in the Morris Water Maze (MWM). This strain may be useful for studying protein function in neuronal injury.
A loxP-flanked neomycin resistance cassette is inserted upstream of exon 4 followed by a loxP site downstream of exon 9. The construct was electroporated into unspecified embryonic stem (ES) cells. Correctly targeted ES cells were injected into recipient blastocysts and the resulting chimeric animals were crossed to FVB/N mice for at least 13 generations.
|Allele Name||targeted mutation 1, Stan Krajewski|
|Allele Type||Targeted (Conditional ready (e.g. floxed))|
|Allele Synonym(s)||Calp; capns1flox|
|Gene Symbol and Name||Capns1, calpain, small subunit 1|
|Strain of Origin||Not Specified|
|Molecular Note||A loxP-flanked neomycin resistance cassette is inserted upstream of exon 4 followed by a loxP site downstream of exon 9.|
While maintaining a live colony, these mice are bred as heterozygotes, specifically the donating investigator recommends heterozygous female x wild-type male. This allele results in embryonic lethality in the homozygous state.
When using the capns1flox mouse strain in a publication, please cite the originating article(s) and include MMRRC stock #37582 in your Materials and Methods section.